RxDoctor Payments Data

Lisa Dugger, NP

Family · Knoxville, TNNPI 1083615868

Payments from drug & device makers

$3,258in general payments, 2019–2025

Across 127 payments — averaging $25.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$800
  • Boston Scientific$496
  • Amgen$399
  • Novartis$304
  • Abbott$215
  • Atricure, Inc.$148
  • plus $896 from 18 others

What the payments were for

  • Food & beverage$3,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,258 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$99,765
Medicare patients
466
Services billed
2,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban250$316,652
XareltoRivaroxaban80$79,686
Nebivolol Hcl107$6,176
Metoprolol Succinate207$3,806
Dofetilide11$3,567
Flecainide Acetate86$2,992
Eplerenone21$1,852
Amiodarone Hcl50$981
Bumetanide21$755
Atorvastatin Calcium75$674
Losartan Potassium74$657
Metoprolol Tartrate63$648
Carvedilol70$591
ClopidogrelClopidogrel Bisulfate58$554
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$85$316,652250 claims
Johnson & JohnsonXarelto$61$79,68680 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →